Article > J&J's Zytiga impresses for castration-resistant prostate cancer

[unable to retrieve full-text content]A late-stage trial of Johnson & Johnson's Zytiga has been unblinded due its effectiveness in patients with castration-resistant prostate cancer. The healthcare giant's Janssen unit says that its second Zytiga (abiraterone) Phase ...

Source: http://www.pharmatimes.com/Article/12-03-09/J_J_s_Zytiga_impresses_for_castration-resistant_prostate_cancer.aspx

r kelly r. kelly macular degeneration whitney houston funeral judi dench alicia keys bobby brown leaves funeral